← Back to All US Stocks

HST Global, Inc. (HSTC) Stock Fundamental Analysis & AI Rating 2026

HSTC OTC Pharmaceutical Preparations NV CIK: 0000797564
Recently Updated • Analysis: Apr 11, 2026 • SEC Data: 2024-09-30
Combined AI Rating
STRONG SELL
86% Confidence
STRONG AGREEMENT
STRONG SELL
95% Conf
STRONG SELL
78% Conf

📊 HSTC Key Takeaways

Revenue: $0.0
Net Margin: N/A
Free Cash Flow: $-35.6K
Current Ratio: 0.25x
Debt/Equity: 0.00x
EPS: $0.00
AI Rating: STRONG SELL with 95% confidence
HST Global, Inc. (HSTC) receives a STRONG SELL rating with 86% confidence from our AI fundamental analysis based on SEC 10-K filings. With revenue of $0, and return on equity (ROE) of -5.2%, HST Global, Inc. demonstrates mixed fundamentals in the Healthcare sector. Below is our complete HSTC stock analysis for 2026.

Is HST Global, Inc. (HSTC) a Good Investment?

Claude

HST Global is a dormant or shell company with zero revenue, negative operating cash flow of -$32.7K, and critically depleted cash reserves of only $10.4K. With a current ratio of 0.25x, the company cannot meet short-term obligations and faces imminent liquidity crisis and likely insolvency within months.

ChatGPT

HST Global is pre-revenue with ongoing losses, extremely weak liquidity (0.25x current ratio) and minimal cash ($10.4K), indicating material going‑concern risk. Despite low liabilities and no debt, the absence of revenue and negative operating cash flow suggest near‑term dependence on external financing or asset sales.

Why Buy HST Global, Inc. Stock? HSTC Key Strengths

Claude
  • + Minimal debt burden with Debt/Equity ratio of 0.00x reduces bankruptcy risk from leverage
  • + Remaining stockholders equity of $1.2M provides slight asset cushion
  • + Low operating expenses suggest potential for rapid pivoting if capital is secured
ChatGPT
  • + Minimal liabilities and no long-term debt (0.00x D/E)
  • + Positive shareholders’ equity (~$1.24M)
  • + Low absolute cash burn relative to microcap scale

HSTC Stock Risks: HST Global, Inc. Investment Risks

Claude
  • ! Zero revenue indicates complete absence of business operations or market traction
  • ! Critical liquidity crisis with current ratio of 0.25x and only $10.4K cash; insolvency likely within months
  • ! Negative operating cash flow of -$32.7K with no revenue path means immediate cash depletion
  • ! Zero insider trading activity in 90 days suggests complete management disengagement
  • ! OTC market status increases execution risk and limits capital raising options
ChatGPT
  • ! Zero revenue with continued operating losses
  • ! Severe liquidity constraints and limited cash runway
  • ! High dilution/financing dependency with negative interest coverage

Key Metrics to Watch

Claude
  • * Cash balance and monthly burn rate (critical threshold approaching)
  • * Emergence of any revenue or business activity
  • * Current ratio and ability to meet short-term liabilities
  • * Management activity and insider trading resumption
  • * Potential merger, acquisition, or restructuring announcements
ChatGPT
  • * Cash balance and operating cash burn
  • * Revenue initiation and operating margin

HST Global, Inc. (HSTC) Financial Metrics & Key Ratios

Revenue
$0.0
Net Income
$-64.6K
EPS (Diluted)
$0.00
Free Cash Flow
$-35.6K
Total Assets
$1.3M
Cash Position
$10.4K

💡 AI Analyst Insight

The current ratio below 1.0x warrants monitoring of short-term liquidity.

HSTC Profit Margin, ROE & Profitability Analysis

Gross Margin N/A
Operating Margin N/A
Net Margin N/A
ROE -5.2%
ROA -5.0%
FCF Margin N/A

HSTC vs Healthcare Sector: How HST Global, Inc. Compares

How HST Global, Inc. compares to Healthcare sector averages

Net Margin
HSTC 0.0%
vs
Sector Avg 12.0%
HSTC Sector
ROE
HSTC -5.2%
vs
Sector Avg 15.0%
HSTC Sector
Current Ratio
HSTC 0.2x
vs
Sector Avg 2.0x
HSTC Sector
Debt/Equity
HSTC 0.0x
vs
Sector Avg 0.6x
HSTC Sector

Sector benchmarks are approximate industry averages. Actual sector performance may vary.

Is HST Global, Inc. Stock Overvalued? HSTC Valuation Analysis 2026

Based on fundamental analysis, HST Global, Inc. has mixed fundamental signals relative to the Healthcare sector in 2026.

Return on Equity
-5.2%
Sector avg: 15%
Net Profit Margin
N/A
Sector avg: 12%
Revenue Growth
N/A
Year-over-year
Debt/Equity
0.00x
Sector avg: 0.6x

Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.

HST Global, Inc. Balance Sheet: HSTC Debt, Cash & Liquidity

Current Ratio
0.25x
Quick Ratio
0.25x
Debt/Equity
0.00x
Debt/Assets
3.3%
Interest Coverage
-31.86x
Long-term Debt
N/A

HSTC Revenue & Earnings Growth: 5-Year Financial Trend

HSTC 5-year financial data: Year 2019: Revenue $0, Net Income -$178.3K, EPS N/A. Year 2020: Revenue $0, Net Income $426.6K, EPS N/A. Year 2021: Revenue $0, Net Income -$209.0K, EPS N/A. Year 2022: Revenue $0, Net Income -$148.4K, EPS $-0.03. Year 2023: Revenue $0, Net Income -$145.1K, EPS $-0.03.
Revenue
Net Income
EPS (right axis)

5-Year Trend Summary: HST Global, Inc.'s revenue has remained relatively flat over the 5-year period, with a 0% decline. The most recent EPS of $-0.03 indicates the company is currently unprofitable.

HSTC Revenue Growth, EPS Growth & YoY Performance

Revenue Growth
N/A
Year-over-year
Net Income Growth
N/A
Year-over-year
EPS Growth
N/A
Earnings per share
FCF Margin
N/A
Free cash flow / Revenue

HSTC Quarterly Earnings & Performance

Quarterly financial performance data for HST Global, Inc. including revenue, net income, and earnings per share.
Quarter Revenue Net Income EPS
Q3 2024 N/A -$13.8K $0.00
Q2 2024 N/A -$16.6K $0.00
Q1 2024 N/A -$34.2K $-0.01
Q3 2023 N/A -$35.6K $-0.01
Q2 2023 N/A -$34.3K $-0.01
Q1 2023 N/A -$38.2K N/A
Q3 2022 N/A -$35.3K $-0.01
Q2 2022 N/A -$35.5K $-0.01

Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.

HST Global, Inc. Dividends, Buybacks & Capital Allocation

Operating Cash Flow
-$32.7K
Cash generated from operations
Capital Expenditures
-$2.9K
Investment in assets
Dividends
None
No dividend program

HSTC SEC Filings: Latest 10-K & 10-Q Analysis

Access official SEC EDGAR filings for HST Global, Inc. (CIK: 0000797564)

📋 Recent SEC Filings

Date Form Document Action
Nov 3, 2025 10-K hstc2024auditedfinancial.htm View →
Mar 20, 2025 8-K hstcform8-kqwyitacquisitionm.htm View →
Nov 22, 2024 10-Q hstc-20240930.htm View →
Nov 12, 2024 8-K hstcform8-kamnionacquisition.htm View →
Sep 26, 2024 8-K hstcform8-ktradenametrademar.htm View →

Frequently Asked Questions about HSTC

What is the AI rating for HSTC?

HST Global, Inc. (HSTC) has a Combined AI Rating of STRONG SELL from Claude (STRONG SELL) and ChatGPT (STRONG SELL) with 86% combined confidence, based on fundamental analysis of SEC EDGAR filings.

What are HSTC's key strengths?

Claude: Minimal debt burden with Debt/Equity ratio of 0.00x reduces bankruptcy risk from leverage. Remaining stockholders equity of $1.2M provides slight asset cushion. ChatGPT: Minimal liabilities and no long-term debt (0.00x D/E). Positive shareholders’ equity (~$1.24M).

What are the risks of investing in HSTC?

Claude: Zero revenue indicates complete absence of business operations or market traction. Critical liquidity crisis with current ratio of 0.25x and only $10.4K cash; insolvency likely within months. ChatGPT: Zero revenue with continued operating losses. Severe liquidity constraints and limited cash runway.

What is HSTC's revenue and growth?

HST Global, Inc. reported revenue of $0.0.

Does HSTC pay dividends?

HST Global, Inc. does not currently pay dividends.

Where can I find HSTC SEC filings?

Official SEC filings for HST Global, Inc. (CIK: 0000797564) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.

What is HSTC's EPS?

HST Global, Inc. has a diluted EPS of $0.00.

How is the AI analysis conducted?

Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.

Is HSTC a good stock to buy right now?

Based on our AI fundamental analysis in April 2026, HST Global, Inc. has a STRONG SELL rating with 86% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.

Is HSTC stock overvalued or undervalued?

Valuation metrics for HSTC: ROE of -5.2% (sector avg: 15%), net margin of N/A (sector avg: 12%). Compare these metrics with sector averages to assess valuation.

Should I buy HSTC stock in 2026?

Our dual AI analysis gives HST Global, Inc. a combined STRONG SELL rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.

What is HSTC's free cash flow?

HST Global, Inc.'s operating cash flow is $-32.7K, with capital expenditures of $2.9K.

How does HSTC compare to other Healthcare stocks?

Vs Healthcare sector averages: Net margin N/A (avg: 12%), ROE -5.2% (avg: 15%), current ratio 0.25 (avg: 2).

Top Rated Stocks
NSSC 92% MLI 92% MELI 92% MDXG 92% MANH 92% INVA 92% GGG 92% GCT 92% FTNT 92% FSLR 92%
Sector: All Healthcare Stocks →
Disclaimer: This analysis is generated by Claude AI (Anthropic) and ChatGPT (OpenAI) based on publicly available SEC EDGAR filings. It does not include stock price data and should not be considered financial advice. All fundamental data is sourced from SEC public domain filings. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.
Data Source: SEC EDGAR | Analysis Date: Apr 11, 2026 | Data as of: 2024-09-30 | Powered by Claude AI